HealthVerity, Inc. introduced MOM, the Maternal Outcomes Masterset to address the dearth of trustworthy data regarding drug safety during pregnancy and gain insight into the health outcomes of pregnancy and the mother-child interaction.
Nuvo Group Ltd. a pioneer in integrated pregnancy care and women's health teamed up with LAMF Global Ventures Corp I launched INVU a remote pregnancy monitoring platform currently used by pregnant women in the United States that helps to monitor heart rates of both the mother and the fetus to helps pregnant parents follow their recommended care.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 5424
Published Date: Nov 30, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
The growing prevalence of pelvic organ prolapse (POP) in the female population across the globe and the growing development of advanced and new pelvic organ prolapse repair devices are the major factors driving the growth of the market.
The market size of pelvic organ prolapse repair is anticipated to attain a CAGR of 5% over the forecast period, i.e., 2024-2036.
The major players in the market are CooperSurgical, Inc., Dr. Arabin GmbH & Co. KG, Integra LifeSciences, Utah Medical Products, Inc., Shenzhen XFT Medical Limited, Sunmedix Co, Ltd., Verity Medical Ltd, Neomedic, and Johnson & Johnson Services, Inc., Coloplast Pty Ltd, Boston Scientific Corporation, and others.
The non-surgical segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.
The market in the North American region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.